Medication info
Monka Tablet 10 mg (Montelukast Sodium)

Monka Tablet 10 mg (Montelukast Sodium)

Prescription medicationTabletOral
Ingredient · strength
Montelukast Sodium›10.4mg / 1 tablet
Manufacturer / importer
Il Sung IS Co., Ltd.
Appearance
Beige, rounded square film-coated tablets
Packaging
28 tablets (7 tablets/PTPX4)
Approval status
Active

MFDS item code 201903262 · Approved 2019.05.21 · Insurance code 655404520

Summary

Main use
Prevention and treatment of asthma; relief of symptoms of seasonal and perennial allergic rhinitis
Who takes it
Adults
Adult dose
Take this medicine once daily. For patients with asthma, take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 sheet once daily in the evening. Asthma or allergic rhinitis 10 mg tablet Adults and adolescents aged 15 years or older: Administer 10 mg of montelukast orally once daily.

Ingredients

Manufacturer
Il Sung IS Co., Ltd.

Efficacy & effects

Prevention and treatment of asthma; relief of symptoms of seasonal and perennial allergic rhinitis

  • Asthma
  • symptoms of allergic rhinitis
View approved original text

This medication helps to prevent and manage asthma continuously. It is also used to relieve symptoms of allergic rhinitis that occur seasonally or throughout the year.

How to take

Adult dose

Take this medicine once daily. For patients with asthma, take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 sheet once daily in the evening. Asthma or allergic rhinitis 10 mg tablet Adults and adolescents aged 15 years or older: Administer 10 mg of montelukast orally once daily.

Precautions

This medication is used to treat asthma and allergic rhinitis. During treatment, neurological and psychiatric symptoms may occur, so patients and caregivers should pay attention to new neurological or psychiatric symptoms or behavioral changes. If symptoms such as anxiety, depression, hallucinations, or suicidal thoughts arise, discontinue use immediately and consult a physician. This medication contains the artificial sweetener Aspartame, so patients with the genetic condition Phenylketonuria should limit its use. Patients with genetic conditions such as galactose intolerance, lactose deficiency, or glucose-galactose malabsorption should not take this medication if it contains lactose. This medication is not a treatment for acute asthma attacks; therefore, appropriate emergency medication must always be available during acute symptoms. The dosage of inhaled corticosteroid preparations may be gradually decreased during treatment, but corticosteroid preparations should not be suddenly switched to this medication. This medication should not be used alone for treating exercise-induced bronchoconstriction; the use of inhaled β-agonists should continue if necessary. Patients with aspirin hypersensitivity should avoid taking aspirin or non-steroidal anti-inflammatory drugs while using this medication. Rarely, symptoms of systemic eosinophilia and vasculitis may appear, so the physician should closely monitor the patient. This medication has not shown an increase in adverse reactions when used with other asthma medications, and interactions with multiple drugs are generally minimal. During pregnancy, it should be administered cautiously only when necessary, and caution is also required during breastfeeding. Safety has been relatively established in children and the elderly, but the safety and efficacy in children under 6 months have not been established. There is no specific antidote in case of overdose, so general treatment and clinical monitoring are necessary. This medication should be stored out of the reach of children, and care should be taken not to transfer it to another container as this may affect its quality. Even when there are no asthma symptoms, this medication should be taken regularly, and if symptoms worsen, consultation with a physician is essential. If symptoms suddenly worsen during treatment or the use of rescue inhalers increases, immediate medical attention is required. Patients should not arbitrarily reduce or discontinue other asthma treatments during use, and those with exercise-induced asthma should continue using inhaled β-agonists for prevention. If neurological or psychiatric symptoms occur, inform the physician immediately, and patients with aspirin hypersensitivity should avoid taking aspirin or non-steroidal anti-inflammatory drugs.

Side effects

  • nervousness
  • aggressive behavior
  • anxiety
  • depression
  • disorientation
  • attention deficit
  • stuttering
  • sleep disorders
  • hallucinations
  • insomnia
Show 81 more
  • memory impairment
  • obsessive-compulsive disorder
  • psychomotor hyperactivity
  • sleepwalking
  • suicidal thoughts and behaviors
  • tics
  • asthenia
  • fatigue
  • fever
  • abdominal pain
  • trauma
  • dyspepsia
  • infectious gastroenteritis
  • toothache
  • dizziness
  • headache
  • nasal congestion
  • cough
  • influenza
  • rash
  • elevated ALT
  • elevated AST
  • pyuria
  • pharyngitis
  • sinusitis
  • nausea
  • diarrhea
  • loss of appetite
  • otalgia
  • viral infection
  • laryngitis
  • (infectious) rhinitis
  • chickenpox
  • gastroenteritis
  • atopic dermatitis
  • acute bronchitis
  • dental infection
  • skin infection
  • myopia
  • rhinorrhea
  • ear pain
  • gastrointestinal inflammation
  • eczema
  • urticaria
  • pneumonia
  • dermatitis
  • conjunctivitis
  • upper respiratory infection
  • wheezing
  • otitis media
  • tonsillitis
  • drowsiness
  • sensory disturbance
  • sensory reduction
  • convulsive seizures
  • palpitations
  • epistaxis
  • pulmonary eosinophilia
  • vomiting
  • cholestatic hepatitis
  • hepatocellular liver damage
  • mixed liver damage
  • angioedema
  • bruising
  • erythema multiforme
  • nodular erythema
  • itching
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • arthralgia
  • muscle cramps
  • myalgia
  • enuresis
  • edema
  • systemic eosinophilia
  • vasculitis
  • thrombocytopenia
  • increased bleeding frequency
  • alopecia
  • thirst
  • psychomotor agitation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air, moisture, and light, and should be stored in a tightly sealed container. Additionally, it is best to store it at room temperature, which is neither too hot nor too cold, ideally between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Beige, rounded square film-coated tablets

Package unit

28 tablets (7 tablets/PTPX4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.